SGMT · ISSUER CIK 1400118
Sagimet Biosciences Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Sagimet Biosciences Inc. insiders reported $0.00 of open-market purchases and $3.8M of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3.8MInsider selling
−$3.8MNet open-market
Aug 17, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 202616:05 | Aug 14, 2026 | SGMT | Director | S · Sell10b5-1 | $10.23 | −350,987 | 62,161 | -85% | −$3.6M | ||
| Aug 17, 202616:05 | Aug 14, 2026 | SGMT | Director | M · Exercise10b5-1 | $6.36 | +350,987 | 413,148 | +565% | $2.2M | ||
| Aug 12, 202619:41 | Aug 11, 2026 | SGMT | Director | S · Sell10b5-1 | $9.95 | −20,206 | 62,161 | -25% | −$201K | ||
| Aug 12, 202619:41 | Aug 11, 2026 | SGMT | Director | M · Exercise10b5-1 | $6.36 | +20,206 | 82,367 | +33% | $129K |